The developing retatrutide vendor landscape is significantly shifting , presenting complexities for drug developers . Currently, the number of established suppliers is fairly small , primarily concentrated on custom synthesis providers . Location is predominantly located in China, with expanding presence from Western suppliers. Securing a reliable